BC10 Cost Effective Best Peptides Research-Grade Lyophilized Polypeptide Powder Factory Direct Sales From China Fast Delivery Upon Order
TDS 26 Inquiries
121062-08-6
Research Grade
99%
HONGKONG
YX
5 mg*10vials,10 mg*10vials 10vials/box
2027-02-09
polypeptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceMelanotan (MT)-II, a synthetic melanocortin receptor agonist, is an peptide hormone used to promote tanning.Certificates
-
TDS
Basic Info-
Product Name:
Mt-2
Other Name:melanotan-II;Melanotan II;MT-II;Melanotan (MT)-II;Melatonan;Melanotan II acetate salt;CHEMBL430239;(3S,6S,9R,12S,15S,23S)-12-((1H-imidazol-5-yl)methyl)-3-((1H-indol-3-yl)methyl)-15-((S)-2-acetamidohexanamido)-9-benzyl-6-(3-guanidinopropyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexaazacyclotricosane-23-carboxamide;L-Lysinamide, N-acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-, cyclic (2-7)-peptide
CAS No.:121062-08-6
Molecular Formula:C50H69N15O9
InChIKeys:JDKLPDJLXHXHNV-MFVUMRCOSA-N
Molecular Weight:1024.18
Exact Mass:1023.540283
EC Number:1308068-626-2
UNII:UPF5CJ93X7
DSSTox ID:DTXSID90153135
Categories:
Characteristics-
PSA:
382.26000
XLogP3:-1.27
Appearance:white solid
Density:1.4±0.1 g/cm3
Refractive Index:1.683
Water Solubility:H2O: 5 mg/mL, soluble
Storage Conditions:−20°C
Research-
Class:
Synthetic cyclic heptapeptide / non-selective melanocortin receptor agonist
Status:Research compound — NOT FDA approved. FDA issued warning letters. WADA banned substance.
Mechanism:A synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) analog of α-MSH. Melanotan II is a high-affinity non-selective agonist at MC1R, MC3R, MC4R, and MC5R. MC1R activation induces melanogenesis (skin darkening/tanning); MC4R activation affects sexual function, appetite suppression, and energy homeostasis. Carries significant safety risks including nausea, hypertension, and priapism.
EC50 (Human Mc1r Ki):1.2 nM
EC50 (Human Mc5r Ki):1.0 nM
EC50 (Human Mc3r Ki):1.1 nM
EC50 (Human Mc4r Ki):2.1 nM
Source:Wikberg JES, et al. Pharmacol Res. 2000;42(5):393–420. PubChem CID 92432.DOI
Clinical Development:
References-
ChEMBL:
CHEMBL363210
PubChem:Literature:FDA Warning Letters: Melanotan II (unapproved drug); WADA Prohibited List: Melanotan II (S2 hormone modulator)
Disclaimer:Melanotan II is NOT FDA-approved. The FDA has issued multiple warning letters to companies illegally selling Melanotan II as an unapproved new drug. It is also listed on the WADA Prohibited List as a banned substance in sport. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
polypeptide
-
Location:
No. 4, 4th Floor, Building D1, Bili La Park, Lu Shang Road, Dongcheng Street, Economic and Technological Development Zone, Liaocheng City, Shandong Province
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
101-200
-
Year of Establishment:
2025
-
Certifications:
Tirzepatide,Tirzepatide
-
-
Inquiry History26 Inquiries
Country Product Purchase Quantity Date Posted
United Kingdom
mt-2
10 MG Jun 23, 2026
Ireland
Melanotan 2
1 KG Nov 10, 2025
United States
Melanotan 2 acetate
10 mg May 23, 2025
United Kingdom
Melanotan 2
10 mg Dec 6, 2024
South Africa
sameglutide;
5 mg Dec 2, 2024
Switzerland
Melanotan 2
50 mg Apr 14, 2024
United States
Melanotan 2
2 G Feb 4, 2024
Australia
MT2
20 Dec 7, 2023
Australia
Melanotan
1 KG Sep 15, 2023
United States
MELANOTAN 2
10 Aug 25, 2023
Germany
melanotan 2
10 MG Jun 15, 2026
Poland
melanotan 2
1 KG Apr 24, 2026
United Kingdom
Melanotan II
2 Apr 3, 2026
Sweden
Mt-2
2 MT Mar 3, 2026
Sweden
Melanotan 2
10 Dec 8, 2025
United Kingdom
Melanotan II
1 KG Jul 28, 2025
United Kingdom
Melanotan II
500 G Jun 30, 2025
Paraguay
Melanotan 2
10 mg Dec 15, 2024
South Africa
sameglutide; tirzepatide;retatrutide
5 mg Nov 29, 2024
Australia
Melanotan II
10 Aug 30, 2024 Post an enquiry for this product